The Latest Breaking News from Mick Farrell

CPAP machine maker posts record revenue but shares sink

Resmed shares have fallen nearly five per cent after inflation took a toll on the sleep apnoea company's gross profit margin.

AAP · Aug 7

Snoring leader buys restless leg syndrome device maker

Sleep apnoea company Resmed has acquired a California firm that makes a device for patients with restless leg syndrome, the third-biggest sleep disorder.

AAP · May 1

Ozempic-style drugs prove to be 'a tailwind' for Resmed

Resmed has beaten expectations with $2 billion in second-quarter revenue and says weight loss drugs are actually boosting sales, rather than hurting them.

AAP · Jan 30

ResMed rings up record $1B in sales in latest quarter led by connected sleep apnea devices

For the past 18 months, ResMed Chief Executive Mick Farrell has been publicly outspoken in urging that medical devices get priority access to semiconductors amid global chip shortages coming out of the pandemic.

Tribune News Service · Jan 28, 2023

Modern leadership and the changing definition of resiliency

Step one: We’re going to need a new definition of resiliency.

Fortune · Nov 9, 2022

ResMed's Q3 Earnings Short Of Expectations, Profit Margins Contract

ResMed Inc's (NYSE:RMD) Q3 FY22 sales increased by 12% Y/Y (+14% on a constant currency basis) to $864.5 million, missing the consensus of $897 million. The revenue growth was driven by increased demand for sleep and respiratory care devices and an increased demand following an ongoing recall of rival Koninklijke Philips N.V. (NYSE:PHG) products. ResMed…

Benzinga · Apr 29, 2022